Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3. This reflects a technical site update and does not modify the study content or displayed results.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a minor administrative update to the study record.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.0 was added; Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedSponsor and affiliated institutions names updated to the official branding: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University and Thomas Jefferson University (Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University) replace the previous names.SummaryDifference0.3%

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.